MeiraGTx Holdings (MGTX) Total Non-Current Liabilities (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Total Non-Current Liabilities came in at $248.8 million in Q4 2025, up 24.97% YoY from $199.1 million in Q4 2024, and up 8.82% on a QoQ basis from $228.7 million in Q3 2025.

MeiraGTx Holdings (MGTX) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Total Non-Current Liabilities data on file, last reported at $248.8 million in Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 24.97% year-over-year to $248.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $248.8 million (up 24.97% YoY) and the FY2025 annual result came in at $248.8 million, up 24.97% from the prior year.
  • Total Non-Current Liabilities grew to $248.8 million in Q4 2025, from $228.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $248.8 million in Q4 2025 to a low of $108.4 million in Q2 2022.
  • A 5-year average of $173.0 million and a median of $184.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities fell 9.03% — and 2023, when it soared 70.16%.
  • Tracing MGTX's Total Non-Current Liabilities over 5 years: stood at $132.7 million in 2021, then jumped by 49.47% to $198.3 million in 2022, then declined by 6.13% to $186.2 million in 2023, then climbed by 6.95% to $199.1 million in 2024, then climbed by 24.97% to $248.8 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $248.8 million (Q4 2025), $228.7 million (Q3 2025), and $194.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 MeiraGTx Holdings 1.10 Bn 1.03 Bn - 248.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 248.82 Mn
Sep 30, 2025 228.66 Mn
Jun 30, 2025 194.30 Mn
Mar 31, 2025 189.57 Mn
Dec 31, 2024 199.10 Mn
Sep 30, 2024 200.87 Mn
Jun 30, 2024 184.12 Mn
Mar 31, 2024 185.06 Mn
Dec 31, 2023 186.17 Mn
Sep 30, 2023 172.99 Mn
Jun 30, 2023 184.44 Mn
Mar 31, 2023 195.68 Mn
Dec 31, 2022 198.32 Mn
Sep 30, 2022 176.66 Mn
Jun 30, 2022 108.39 Mn
Mar 31, 2022 124.30 Mn
Dec 31, 2021 132.68 Mn
Sep 30, 2021 113.58 Mn
Jun 30, 2021 119.15 Mn
Mar 31, 2021 117.03 Mn